Clinical trials
Recruiting Cardiotoxicity trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ass. Prof. Jan Nyman | 1 |
| Erasmus Medical Center | 1 |
| Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| Norwegian School of Sport Sciences | 1 |
| Norwegian University of Science and Technology | 1 |
| Odense University Hospital | 1 |
| Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | 1 |
| University Health Network, Toronto | 1 |
| University of Alberta | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiotoxicity | 12 |
| Breast Neoplasms | 6 |
| Heart Failure | 3 |
| Neoplasms | 3 |
| Lymphoma | 2 |
| Cardiovascular Diseases | 1 |
| Chemically-Induced Disorders | 1 |
| Colonic Neoplasms | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Multiple Myeloma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.